Clinical Trials Directory

Trials / Completed

CompletedNCT02128009

Study on the microRNA Expression Level in Postmenopausal Osteoporosis

Study on the Molecular Mechanism in Postmenopausal Osteoporosis With Kidney Yin Deficiency Syndrome Based on miRNA Mediated Gene Translation Regulation Function by Targeting CLCF1

Status
Completed
Phase
Study type
Observational
Enrollment
60 (actual)
Sponsor
Fujian Academy of Traditional Chinese Medicine · Academic / Other
Sex
Female
Age
45 Years – 75 Years
Healthy volunteers
Accepted

Summary

The miRNA plays an important regulation role in gene expression, and also closely related to bone metabolism. Previous research found that postmenopausal osteoporosis with kidney Yin deficiency syndrome (POP) is associated with CLCF1 gene. This project proposed by bioinformatics prediction CLCF1 targeted regulation of miRNAs, and use the 3 'UTR dual luciferase report system for target validation, aimed at the miRNA levels to explore postmenopausal osteoporosis molecular mechanism with kidney Yin deficiency syndrome.

Conditions

Interventions

TypeNameDescription
OTHERosteoporosis

Timeline

Start date
2014-02-01
Primary completion
2016-12-01
Completion
2017-01-01
First posted
2014-05-01
Last updated
2019-02-26

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02128009. Inclusion in this directory is not an endorsement.